Menopause Transition and Vascular Function Study

This study is looking at how the menopause transition affects your body's automatic functions (like heart rate and blood pressure) and blood vessel health. Researchers want to understand why women after menopause might have different responses to stress compared to men or younger women. This is an observational study, meaning there are no interventions or treatments being tested. We are looking for women aged 45-55 who are premenopausal and not taking medications that affect automatic body functions. The study will measure nerve activity related to blood pressure over up to 5 years to see how these changes occur during menopause.

Study design
This is an observational study, meaning there are no interventions or treatments. It plans to enroll 100 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 5 years to measure nerve activity.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06490146

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

Recruiting
Not specifiedAges 45–55Observational
University of Minnesota
~100 participants
Updated 2026-05-20 on ClinicalTrials.gov
What's tested:No intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
MSNA- Burst frequency
Measured over up to 5 years
+2 more outcomes measured
Menopause
1 sites across 1 states
Minnesota1
  • Manda Keller-Ross · PRINCIPAL_INVESTIGATOR · University of Minnesota

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female
age 45-55 years
premenopausal
not using any medications determined to affect autonomic function
eumenorrheic
not planning to become pregnant for the duration of participation in the study
English-speaking, literate, willing and able to provide informed consent.

Exclusion

Diabetes
pregnant or breastfeeding
cardiac or pulmonary disorders
severe obesity (body mass index \[BMI\] ≥ 40 kg/m 2 )
hypertension
obstructive sleep apnea
current use of heart or blood pressure medications, current use of hormonal contraceptives or other forms of exogenous sex hormones
report of nicotine/tobacco use in the last six months, report of current alcohol abuse,
history of treatment with chemotherapy/radiation
coagulopathy disorders and/or use of anticoagulant medications, and current use of anxiolytics and/or antidepressants.
  • MSNA- Burst frequencyup to 5 years

    measured in bursts/min Microneurography to measure MSNA: Microneurography is a direct measurement of electrical activity of peripheral sympathetic nerves. A tungsten microelectrode is placed in a peripheral nerve (Figure 8) to record real-time activity from efferent sympathetic vasoconstrictor nerve fibers. MSNA is the gold-standard measure for sympathetic activity Participants attend experimental visits annually until they enter perimenopause, at which point they will attend such visits every six months.

  • MSNA- Burst incidenceup to 5 years

    measured in bursts/100 heartbeats Microneurography to measure MSNA: Microneurography is a direct measurement of electrical activity of peripheral sympathetic nerves. A tungsten microelectrode is placed in a peripheral nerve (Figure 8) to record real-time activity from efferent sympathetic vasoconstrictor nerve fibers. MSNA is the gold-standard measure for sympathetic activity Participants attend experimental visits annually until they enter perimenopause, at which point they will attend such visits every six months.

  • MSNA- total activityup to 5 years

    Microneurography to measure MSNA: Microneurography is a direct measurement of electrical activity of peripheral sympathetic nerves. A tungsten microelectrode is placed in a peripheral nerve (Figure 8) to record real-time activity from efferent sympathetic vasoconstrictor nerve fibers. MSNA is the gold-standard measure for sympathetic activity Participants attend experimental visits annually until they enter perimenopause, at which point they will attend such visits every six months.